Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
U.S. drug industry group defends price of Gilead hepatitis drug

The leading U.S. pharmaceutical industry trade group on Thursday defended the cost of Gilead Sciences Inc's new hepatitis C drug, Sovaldi, saying such treatments offer a priceless breakthrough for patients with the liver-destroying virus.

Published
11 April 2014
From
Reuters
Can we provide point-of-care viral load tests in poor countries?

It is not impossible to provide mobile, point-of-care viral load tests in resource-poor settings, the 2014 Treatment as Prevention workshop in Vancouver heard last week. By using a number

Published
10 April 2014
By
Gus Cairns
Egypt: New Treatments May Defuse Viral Hepatitis Time Bomb

Egypt is said officially to have the highest prevalence of hepatitis C in the world, with 10 to 14 percent of its 85 million people infected, and about two million in dire need of treatment. The Egyptian government recently struck a deal with U.S. pharmaceutical firm Gilead Sciences to purchase its new hepatitis C pill Sovaldi at a fraction of its American price.

Published
10 April 2014
From
Inter Press Service
Twenty years after genocide, Rwanda is a model of health equity

Just two decades later, life expectancy has doubled. Vaccination rates for many diseases are now higher than those registered in the United States—more than 97% of Rwandan infants are immunized against ten different diseases. Child mortality has fallen by more than two thirds since 2000. New HIV infection rates fell by 60% between 2000 and 2012, and AIDS-related mortality fell by 82%. HIV treatment is free.

Published
10 April 2014
From
Quartz
HIV's Grip on the American South

One of the strangest things about the H.I.V. epidemic in the Deep South—from Louisiana to Alabama to Mississippi—is how easily most Americans have elided it, choosing instead to imagine that the disease is now an out-there, elsewhere epidemic.

Published
10 April 2014
From
The New Yorker
PROUD UK PrEP study completes enrolment – first data give participants' background and risk factors

The pilot stage of the PROUD study – the UK's study of HIV pre-exposure prophylaxis (HIV-negative people taking HIV drugs to prevent HIV) in gay

Published
09 April 2014
By
Gus Cairns
WHO recommends global use of newest hepatitis C drugs, urges price reductions

The World Health Organization has issued global treatment guidelines for hepatitis C, strongly recommending the use of the new direct-acting antivirals sofosbuvir (Sovaldi) with ribavirin for genotypes 1,

Published
09 April 2014
By
Keith Alcorn
Nano-sized drug particles to expand HIV treatment further

Research at the University of Liverpool could benefit millions of HIV patients in developing countries through a nano-technology programme aimed at making drug treatment more effective.

Published
09 April 2014
From
Medical Xpress
WHO joins clamour to make new hepatitis C pills affordable

The World Health Organisation wants a "concerted effort" to drive down the cost of new hepatitis C drugs that offer a cure for the liver-destroying virus but are unaffordable for most infected people worldwide.

Published
09 April 2014
From
Reuters
WHO issues its first hepatitis C treatment guidelines

WHO has issued its first guidance for the treatment of hepatitis C, a chronic infection that affects an estimated 130 million to 150 million people and results in 350 000 to 500 000 deaths a year.

Published
09 April 2014
From
World Health Organization

Filter by country